Top

Cancer and Metastasis Reviews

Published in:

01-03-2001

Tumor Physiology and Drug Resistance

Author: Ian F. Tannock

Published in: Cancer and Metastasis Reviews | Issue 1-2/2001

Title: Tumor Physiology and Drug Resistance
Author: Ian F. Tannock
Publication date: 01-03-2001
Publisher: Kluwer Academic Publishers
Published in: Cancer and Metastasis Reviews / Issue 1-2/2001
Print ISSN: 0167-7659
Electronic ISSN: 1573-7233
DOI: https://doi.org/10.1023/A:1013125027697

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 1-2/2001

Targeting Molecular Signals in Chk1 Pathways as a New Approach for Overcoming Drug Resistance

Mechanisms Associated with cell Adhesion Mediated Drug Resistance (CAM-DR) in Hematopoietic Malignancies

Instructions for Authors

The Role for Liposomal Drug Delivery in Molecular and Pharmacological Strategies to Overcome Multidrug Resistance

Translational Regulation as a Novel Mechanism for the Development of Cellular Drug Resistance

Intermittent Blood Flow in Solid Tumours – an under-appreciated Source of ‘drug Resistance’

Keynote webinar | Spotlight on antibody–drug conjugates in cancer